Greater Cannabis Company (GCAN) Other Working Capital Changes (2020 - 2021)

Greater Cannabis Company (GCAN) recorded quarterly Other Working Capital Changes of -$10000.0 in Q1 2021, down 126.33% quarter-over-quarter from $37977.0 in Q4 2020.

Greater Cannabis Company (GCAN) Other Working Capital Changes (2020 - 2021) Analysis & Trends

Greater Cannabis Company's Other Working Capital Changes history runs 2 years deep, the most recent figure standing at -$10000.0 for Q1 2021.

  • In Q1 2021, Other Working Capital Changes changed N/A year-over-year to -$10000.0; the TTM figure through Dec 2021 stood at -$10000.0 (changed N/A YoY), while the FY2021 annual figure was -$10000.0, down 200.0% from the prior year.
  • Other Working Capital Changes was -$10000.0 for Q1 2021 at Greater Cannabis Company, down from $37977.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $37977.0 in Q4 2020 to a low of -$10000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Greater Cannabis Company - - -

Historic Data

Download Data
DateValue
Mar 31, 2021 -10,000.00
Mar 31, 2021 -10,000.00
Dec 31, 2020 37,977.00
Dec 31, 2020 37,977.00